Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't ...
ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed. In more than ...
AMSTERDAM -- Venoarterial extracorporeal membrane oxygenation (VA ECMO) didn't improve survival with cardiogenic shock, the ECLS-SHOCK trial showed. This form of extracorporeal life support (ECLS) ...
Please provide your email address to receive an email when new articles are posted on . Delayed ECMO initiation was tied to increased in-hospital mortality among patients with cardiogenic shock. ECMO ...
MADRID, Spain—Ten years after experiencing STEMI complicated by cardiogenic shock, patients treated with the Impella CP device (Abiomed) continue to have a survival advantage over those receiving ...
Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...
Numerous knowledge gaps exist regarding the care of female patients with cardiogenic shock, often because they have been consistently underrepresented in clinical trials, according to a new consensus ...
Women with heart failure–related cardiogenic shock have worse outcomes and more vascular complications than men, a new analysis of registry data shows. "These data identify the need for us to continue ...
Use of a microaxial flow pump (Impella CP) with standard care led to a lower risk for death than standard care alone in patients with ST-elevation myocardial infarction (STEMI)-related cardiogenic ...